, Volume 14, Issue 4, pp 389-391
Date: 10 Jan 2006

Gabapentin in the treatment of severe sweating experienced by advanced cancer patients

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Nine patients with advanced cancer suffering from idiopathic severe sweating were treated with gabapentin (600–1,800 mg/day). All patients responded to the treatment; five patients experienced transient drowsiness. Gabapentin seems to be a safe and effective treatment for idiopathic sweating in advanced cancer patients. Further studies are warranted to confirm or refute these results.